Home

China OTC Player

Submitted by chinastock on Thu, 01/14/2010 - 18:49
Posted in

China OTC play is a blog run by China OTC Player and Platinum Tiger. According to their website:

"We've been investing for over 20 years, and of late, some of these high growth but lesser known companies have presented particularly attractive investments.

We are MBAs (Stanford and Wharton) based in Los Angeles who have lived and worked in Singapore, China, Hong Kong, and other parts of the world, sometimes as investment professionals and sometimes in other fields. Our mission is to enlighten, enthuse and entertain you, our readers, as we pursue profits together via investment in China's new growth companies."

Update: Still Bullish on Biostar Pharma

Submitted by chinastock on Mon, 05/24/2010 - 12:38
Posted in

By Hungry Panda

“Whether we’re talking about socks or stocks, I like buying quality merchandise when it is marked down.” -- Berkshire Hathaway 2008 Chairman's Letter

The capital markets have been gripped by a great deal of fear from a variety of sources. Almost every sector has sustained losses and our Rising China Stocks (RCS) Index is no exception. As contrarians, we believe this is the perfect time to be investing.

Read more »

Update: Market Correction Highlights Chinese Small-Cap Buying Opportunities

Submitted by chinastock on Sat, 05/08/2010 - 10:17
Posted in

By Hungry Panda

Stock market bubbles don't grow out of thin air. They have a solid basis in reality, but reality as distorted by a misconception. -- George Soros

Read more »

Update: Biostar Confirms Rumor; Says "No Impact on Income Guidance"

Submitted by chinastock on Tue, 04/27/2010 - 09:05
Posted in

By Platinum Tiger

Biostar Pharmaceuticals (BSPM.OB) moved swiftly and admirably today to confront investor worries that sent the company's stock tumbling by nearly 20 percent on Monday. The company issued a press release confirming the rumor that the provincial bureau of the Shaanxi State Food and Drug Administration (SFDA) had notified Biostar that it had been using improper language in its marketing materials for its flagship hepatitis drug, Xin Aoxing Oleanolic Acid Capsules.

Read more »

Biostar Plunges on Government Suspension Rumors

Submitted by chinastock on Mon, 04/26/2010 - 23:20
Posted in

By Platinum Tiger

On only the second trading day after Biostar Pharmaceuticals (BSPM) uplisted to the NASDAQ, when investors might have otherwise celebrated the usual price bump that accompanies a move from the bulletin boards to a listed exchange, they were instead surprised on Monday by a 20 percent price drop on massive volume of nearly 2 million shares.

Read more »

Real Estate Stocks Sink Chinese Small Caps for Second Straight Week

Submitted by chinastock on Mon, 04/26/2010 - 01:08
Posted in

By Platinum Tiger

A 10 percent plunge in real estate stocks cooled off the Rising China Stocks (RCS) index for a second consecutive week, wiping out nearly a third of the gains the small cap index had made this year and putting it well off the pace of the red hot Russell 2000 small cap index, which is now up by nearly 20 percent this year.

[Click to Enlarge]

Read more »

Downtrend in Chinese Small Caps Triggers Bearish Alerts

Submitted by chinastock on Thu, 04/22/2010 - 00:21
Posted in

By Platinum Tiger

For the first time this year I find myself writing more about falling Chinese stocks than rising ones. The past several weeks, and the past few sessions in particular, have seen U.S. listed Chinese small caps take a bearish turn, even as the Russell 2000 small cap index has risen to higher closes in each of the past five weeks.

So of the five stocks in the RCS index that have recently signaled new Point & Figure --or "P&F"--alerts, four are bearish. The five are:

Read more »

The Ripple Effect of China's Sagging Real Estate Sector

Submitted by chinastock on Wed, 04/21/2010 - 19:35
Posted in

By Platinum Tiger

The sagging Chinese real estate sector dragged down the 35-issue Rising China Stocks (RCS) index to a half-point loss on Wednesday, its third decline in the past four sessions. Largely because of real estate's 16 percent decline in the past month, and its ripple effect on other sectors, year-to-date returns for the RCS fell behind those of the Russell 2000 small cap index for the first time all year.

[Click to Enlarge]

Read more »

Shanghai Composite Index Tests Year's Lows

Submitted by chinastock on Tue, 04/20/2010 - 01:23
Posted in

By Platinum Tiger

Tuesday morning in China began with the Shanghai Composite index dipping to within a tenth-percent of its low for the year, capping a 7 percent loss for the index in two days. Although the Rising China Stocks index had previously decoupled from the Shanghai index for most of the year, U.S. listed Chinese small caps have recently fallen nearly in lockstep with their large cap counterparts, losing six percent of their value since Friday.

Read more »

Update: Guanwei Recycling Rides the Green Tech Wave

Submitted by chinastock on Mon, 04/19/2010 - 05:01
Posted in

By China OTC Player

Guanwei Recycling (GPRC, formerly GURC.OB) is a company in a hurry to go places. Last week saw its successful uplisting onto the NASDAQ from OTC, and the last few days have seen the stock price breaking through the $5 mark, and staying well above the level. Volume also hit a record, with over 200,000 shares changing hands on 4/14 alone.

The company is one reason why our RCS Index has done so well. To recap its gains, let us revisit the following returns:
1) Since our first buy alert: 6.9% (or 63.4% annualized)

Read more »

'Goldman' Friday Ends Win Streak for Chinese Small Caps

Submitted by chinastock on Sun, 04/18/2010 - 19:34
Posted in

By Platinum Tiger

A negative turn in investor sentiment on Friday sent the Rising China Stocks index tumbling to a 2.5 percent decline, wiping out gains from earlier in the week and dropping the index to its first weekly loss in a month.

Read more »